Diebold Nixdorf, Incorporated DBD
$73.06
+1.14%
at last close
Analyst Consensus
- Consensus Rating
- Buy (2 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $100.00
- Implied Upside
- +36.9%
- Price Target Range
- $100.00 – $100.00
- Analysts (12 mo)
- 2
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-05-04 | DA DavidsonMatthew Summerville |
Maintains | Buy | $100 |
| 2026-04-21 | DA DavidsonMatthew Summerville |
Maintains | Buy | $100 |
| 2026-02-13 | DA DavidsonMatthew Summerville |
Maintains | Buy | $80 → $100 |
| 2026-02-13 | WedbushAntoine Legault |
Maintains | Outperform | $80 → $100 |
| 2026-02-09 | WedbushAntoine Legault |
Reiterates | Outperform | $80 |
| 2025-11-18 | WedbushAntoine Legault |
Reiterates | Outperform | $80 |
| 2025-11-06 | WedbushAntoine Legault |
Maintains | Outperform | $70 → $80 |
| 2025-10-28 | WedbushAntoine Legault |
Reiterates | Outperform | $70 |
| 2025-08-19 | DA DavidsonMatthew Summerville |
Maintains | Buy | $80 |
| 2025-08-07 | WedbushMatt Bryson |
Maintains | Outperform | $60 → $70 |
| 2025-02-27 | DA DavidsonMatthew Summerville |
Maintains | Buy | $65 → $80 |
| 2024-09-12 | WedbushMatt Bryson |
Reiterates | Outperform | $50 |
| 2024-08-09 | DA DavidsonMatthew Summerville |
Maintains | Buy | $55 → $65 |
| 2024-08-08 | WedbushMatt Bryson |
Reiterates | Outperform | $50 |
| 2024-07-25 | WedbushMatt Bryson |
Reiterates | Outperform | $50 |
| 2024-05-03 | WedbushMatt Bryson |
Upgrades | Neutral → Outperform | $40 → $50 |
| 2024-04-25 | WedbushMatt Bryson |
Reiterates | Neutral | $40 |
| 2024-02-15 | WedbushMatt Bryson |
Maintains | Neutral | $25 → $40 |
| 2024-02-12 | WedbushMatt Bryson |
Reiterates | Neutral | $25 |
| 2023-11-10 | DA DavidsonMatthew Summerville |
Upgrades | Neutral → Buy | $25 → $29 |
| 2023-11-10 | WedbushMatt Bryson |
Maintains | Neutral | $20 → $25 |
| 2023-10-30 | WedbushMatt Bryson |
Reiterates | Neutral | $20 |
| 2023-08-18 | WedbushMatt Bryson |
Maintains | Neutral | $1 → $20 |
| 2023-08-15 | DA DavidsonMatthew Summerville |
Reinstates | Neutral | $25 |
| 2023-05-04 | WedbushMatt Bryson |
Downgrades | Outperform → Neutral | $5 → $1 |
| 2023-03-17 | WedbushMatt Bryson |
Reiterates | Outperform | $5 |
| 2022-10-24 | DA DavidsonMatthew Summerville |
Downgrades | Buy → Neutral | $5 → $3 |
| 2022-08-12 | JP MorganPaul Chung |
Downgrades | Neutral → Underweight | — |
| 2022-07-08 | WedbushMatt Bryson |
Upgrades | Neutral → Outperform | $5 |
| 2021-06-21 | WedbushMatt Bryson |
Initiates coverage on | Neutral | $14 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $73.06
- Market Cap
- $2.48 billion
- 52-Week Range
- $53.93 – $92.08
- Average Volume
- 286K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.